N
Nicholas P. Illsley
Researcher at Hackensack University Medical Center
Publications - 79
Citations - 4146
Nicholas P. Illsley is an academic researcher from Hackensack University Medical Center. The author has contributed to research in topics: Glucose transporter & Syncytiotrophoblast. The author has an hindex of 34, co-authored 76 publications receiving 3646 citations. Previous affiliations of Nicholas P. Illsley include University of Medicine and Dentistry of New Jersey & University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
Glucose transporter protein expression in human placenta throughout gestation and in intrauterine growth retardation
TL;DR: GLUT 1 is the main glucose transporter protein isoform in human syncytiotrophoblast, the glucose transport capacity for MVM is potentially approximately 20-fold higher than that of BM, and GLUT 1 densities may be regulated independently in MVM and BM.
Journal ArticleDOI
Glucose transporters in the human placenta.
TL;DR: The GLUT1 glucose transporter, present on both the microvillous and basal membranes of the syncytial barrier, is the primary isoform involved in the transplacental movement of glucose as discussed by the authors.
Journal ArticleDOI
Placental glucose transfer and fetal growth.
TL;DR: The contrast between in vitro and in vivo regulation and the specific changes in GLUT1 distribution suggest more complex regulatory interactions than those yet described.
Journal ArticleDOI
Membrane chloride transport measured using a chloride-sensitive fluorescent probe.
TL;DR: Chloride transport determined with SPQ was validated by measurement of erythrocyte chloride/anion exchange and membrane vesicle chloride conductance.
Journal ArticleDOI
Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.
John Ilekis,Ekaterini Tsilou,Susan J. Fisher,Vikki M. Abrahams,Michael J. Soares,James C. Cross,Stacy Zamudio,Nicholas P. Illsley,Leslie Myatt,Christine M. Colvis,Maged M. Costantine,David M. Haas,Yoel Sadovsky,Carl P. Weiner,Erik Rytting,Gene L. Bidwell +15 more
TL;DR: A major theme that developed from the workshop was that the scientific community must change their thinking of the pregnant woman and her fetus as a vulnerable patient population for which drug development should be avoided, but rather be thought of as a deprived population in need of more effective therapeutic interventions.